Annual CAPEX
N/A
01 December 2023
Summary:
Altamira Therapeutics annual capital expenditures is not available.CYTO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTO CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CYTO CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Altamira Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $2.25 M(-38.3%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $3.64 M | - | - |
FAQ
- What is the all time high annual CAPEX for Altamira Therapeutics?
What is the all time high annual CAPEX for Altamira Therapeutics?
Altamira Therapeutics all-time high annual capital expenditures is $3.64 M